Why is CMO Significant in Global Pharmaceutical Companies?
A predictable route will follow the role played by the CMO—larger CMOs will absorb smaller CMOs. They will develop support for large pharmaceutical and biopharmaceutical companies.
FREMONT, CA: Over the past few years, the pharmaceutical marketplace has changed as companies move from central, internal production to single-source providers or contract manufacturing organizations (CMOs). The explanation behind the landscape evolution is plain, cutting costs, boosting efficiency, and minimizing time-to-market. There are other reasons beyond these criteria why pharmaceutical companies relying on the CMO market. CMO at first produced primary packaging, but now, they provide a multitude of services from design and discovery to the final packaging.
Outsourcing to a CMO enables pharmaceutical companies to add technical resources without rising overhead costs
As a result, the pharmaceutical company does not need to invest in growing its employees and production facilities in order to add new facilities to the product lines. Pharmaceutical companies can now concentrate on the leading R&D and production products and leave their secondary and tertiary products to the CMO.
Finished Dosage Form (FDF) Contract Manufacturer
These are the organizations that provide a patient with a drug product to be administered without the need for substantial further production and often in its final packaged form. Currently, the CMO market is divided nearly equally between manufacturers of APIs and FDFs. Solid dose compounds currently dominate the market in the manufacture of FDF contracts. Nevertheless, injectable dose manufacturing is likely to drive future growth primarily due to the increased focus on the complex disease areas and the growing self-administration trend.
Although the CMO is likely to become a key player in the pharmaceutical marketplace, there are different challenges ahead. The smaller pharmaceutical companies are using CMO services more than the big pharmaceutical companies.
Check This Out: Top Pharma and Life Sciences Tech Solution Companies
CIO Review Client: Flagship
By Leni Kaufman, VP & CIO, Newport News Shipbuilding
By George Evans, CIO, Singing River Health System
By John Kamin, EVP and CIO, Old National Bancorp
By Elliot Garbus, VP-IoT Solutions Group & GM-Automotive...
By Gregory Morrison, SVP & CIO, Cox Enterprises
By Alberto Ruocco, CIO, American Electric Power
By Sam Lamonica, CIO & VP Information Systems, Rosendin...
By Sergey Cherkasov, CIO, PhosAgro
By Pascal Becotte, MD-Global Supply Chain Practice for the...
By Stephen Caulfield, Executive Director, Global Field...
By Shamim Mohammad, SVP & CIO, CarMax
By Ronald Seymore, Managing Director, Enterprise Performance...
By Brad Bodell, SVP and CIO, CNO Financial Group, Inc.
By Jim Whitehurst, CEO, Red Hat
By Clark Golestani, EVP and CIO, Merck
By Scott Craig, Vice President of Product Marketing, Lexmark...
By Dave Kipe, SVP, Global Operations, Scholastic Inc.
By Meerah Rajavel, CIO, Forcepoint
By Amit Bahree, Executive, Global Technology and Innovation,...
By Greg Tacchetti, CIO, State Auto Insurance